Periodic Reporting for period 2 - P-TEV (Personalized Tissue-Engineered Veins as the first Cure for Patients with Chronic Venous Insufficiency)

Summary
VERIGRAFT's technology produces personalised blood vessel transplants. In short, a donated tissue is decellularised, removing donor cells and DNA. The resulting acellular extracellular matrix scaffold is subsequently reconditioned and recellularised with a small sample of...
More information & hyperlinks
Web resources: http://www.verigraft.com